Performance of Celera RUO integrase resistance assay across multiple HIV-1 subtypes

BARC-SA. Lancet Laboratories Johannesgurg, South Africa.
BARC-SA. Lancet Laboratories Johannesgurg, South Africa.
YRG Centre for AIDS Research and Education. Chennai, India.
Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de AIDS e Imunologia Molecular. Rio de Janeiro, RJ. Brasil.
Kemri-CDC, Kenya.
University of Pittsburgh. PA, USA.
University of Pittsburgh. PA, USA.

Abstract

HIV-1 sequence variation is a major obstacle to developing molecular based assays for multiple subtypes. This study sought to independently assess performance characteristics of the ViroSeq™ HIV-1 Integrase RUO Genotyping Kit (Celera, US) for samples of multiple different HIV-1 subtypes.

Keywords in Portuguese

Resistência a Medicamentos
Integrases
HIV

Keywords

HIV-1 drug resistance
Non-subtype B
integrase

Publisher

Elsevier

Citation

WALLIS, Carole L. et al. Performance of Celera RUO integrase resistance assay across multiple HIV-1 subtypes. Journal of Virological Methods, v.241, p.41-45, 2017.

DOI

10.1016/j.jviromet.2016.12.008

ISSN

0166-0934

Please use this identifier to cite or link to this item: https://www.arca.fiocruz.br/handle/icict/23543

Type

Copyright

Restricted access

Embargo date

2030-01-01

Sustainable Development Goals

Collections

Share

Statistics

Metadata

Author

Affilliation